Your browser doesn't support javascript.
loading
Research Progress of Antibody-drug Conjugates in Advanced Non-small Cell Lung Cancer / 中国肺癌杂志
Chinese Journal of Lung Cancer ; (12): 214-218, 2022.
Article Dans Chinois | WPRIM | ID: wpr-928800
ABSTRACT
Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Non-small cell lung cancer (NSCLC) is one of the most important pathological types of lung cancer. The prognosis of advanced NSCLC is poor and medical treatment is still the main treatment option. Antibody-drug conjugates (ADCs) are the kind of potentially new anti-tumor drugs, consisting of monoclonal antibodies conjugated to the cytotoxic payloads via the synthetic linkers. They have a broad application prospect in solid tumors such as lung cancer. This article focuses on the mechanism of action and research progress of ADCs in advanced NSCLC.
.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Carcinome pulmonaire non à petites cellules / Immunoconjugués / Tumeurs du poumon / Anticorps monoclonaux / Antinéoplasiques Type d'étude: Étude pronostique Limites du sujet: Humains langue: Chinois Texte intégral: Chinese Journal of Lung Cancer Année: 2022 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Carcinome pulmonaire non à petites cellules / Immunoconjugués / Tumeurs du poumon / Anticorps monoclonaux / Antinéoplasiques Type d'étude: Étude pronostique Limites du sujet: Humains langue: Chinois Texte intégral: Chinese Journal of Lung Cancer Année: 2022 Type: Article